Moderna surged as much as 22% after the biotech company shipped the first coronavirus vaccine for human testing.
EXCLUSIVE: Coronavirus Bioweapon – How China Stole Coronavirus From Canada And Weaponized It (watch here Visualizing The Secret History Of Coronavirus)
Watch the exclusive interview of Bioweapons Expert Dr. Francis Boyle on Coronavirus Biological Warfare blocked by the Deep State
Moderna Coronavirus Vaccine Ready For Human Testing, Stocks Spike 22%
The firm submitted vials of mRNA-1273 to the National Institute of Allergy and Infectious Diseases for a phase one study in the US, according to a press release. Moderna is the first company to push a preventative vaccine for the outbreak to trial.
The company was able to deliver the first batch just 42 days after identifying the key RNA sequence to target, Juan Andres, chief technical operations and quality officer, said. Andres attri...
Full Access
Included:
-
Access to All Articles.
-
One Plan. No Tiers.
-
No Ads.
-
Cancel anytime.
